$RHHBY kEEP AN EYE ON THIS ONE.
Could consolidate a little but has a priority review PDUFA date of 8/18/19 for Enrectinib solid tumors and ROSI-positive non-small cell lung cancer. Also PDUFA date of 9/2/19 for Tecentriq plus chemo
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.